Variability in Age of Onset, Age of Diagnosis and Age of Death for Progressive Supranuclear Palsy Patients Among Three Racial Groups in Hawai`i
Objective: To examine if differences in age of symptom onset, age of diagnosis, age of death, and number of years lived after diagnosis exist for…Perception-action binding in patients with functional movement disorders
Objective: To analyze cognitive processes engaged in linking and restructuring sensory perception and motor action associations in functional movement disorders (FMD). Background: FMD patients demonstrate…Patients with Parkinson’s Disease Share a Unique Olfactory Perceptual Fingerprint
Objective: To explore potential olfactory biomarkers for early detection of Parkinson's disease Background: Although the olfactory decline in Parkinson’s disease (PD) precedes the motor symptoms…‘Top of the POPPS’ – how we set up an online support group for Partners of People with Parkinson’s.
Objective: To provide useful peer and professional support for partners of people with Parkinson's (PWP)To be able to offer that support in a Covid safe…The use of artificial intelligence-based chatbot in Parkinson’s disease
Objective: This study aimed to assess the feasibility and efficacy of using an artificial intelligence-based chatbot for smile and speech in Parkinson’s disease (PD). Further,…Multidimensional phenotyping of human stem cell-derived midbrain dopaminergic neurons from a SNCA triplication carrier for drug screening applications
Objective: We hypothesized that combining multiple Parkinson's disease (PD) relevant cellular phenotypes will increase the accuracy, stability, and usability of human midbrain dopaminergic (mDA) neuronal…Effect of freezing of gait and antiparkinsonian medication on joint kinematics and kinetics in gait in patients with Parkinson’s disease
Objective: This study aims to evaluate the interaction between FoG and antiparkinsonian medication on individuals with PD's kinematic and kinetic gait parameters. Background: Regarding Parkinson's…Complications in Patients with Progressive Supranuclear Palsy
Objective: This study elucidated the incidence and features of complications in patients with progressive supranuclear palsy (PSP). Background: PSP is a progressive neurodegenerative disorder accompanied…Acute polyneuropathy in patients with Parkinson’s disease treated with LCIG
Objective: The aim of the study was to determine whether the daily dose of levodopa equivalent daily dose (LEDD) before and after starting levodopa/carbidopa intestinal…Identification and functional characterization of genetic modifier of penetrance in G2019S LRRK2-associated Parkinson’s disease through family whole genome sequencing
Objective: Trait- or disease-associated genetic variants contribute to substantial variability and penetrance of complex traits and diseases in humans. Several causative genes and risk factors…
- « Previous Page
- 1
- …
- 134
- 135
- 136
- 137
- 138
- …
- 153
- Next Page »